These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19394307

  • 41. Syndecan-2 expression increases serum-withdrawal-induced apoptosis, mediated by re-distribution of Fas into lipid rafts, in stably transfected Swiss 3T3 cells.
    Villena J, Mainez J, Noguer O, Contreras H, Granés F, Reina M, Fabregat I, Vilaró S.
    Apoptosis; 2006 Nov; 11(11):2065-75. PubMed ID: 17041758
    [Abstract] [Full Text] [Related]

  • 42. Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4.
    Uemura T, Shiozaki K, Yamaguchi K, Miyazaki S, Satomi S, Kato K, Sakuraba H, Miyagi T.
    Oncogene; 2009 Mar 05; 28(9):1218-29. PubMed ID: 19151752
    [Abstract] [Full Text] [Related]

  • 43. C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.
    Kim ES, Kim SY, Koh M, Lee HM, Kim K, Jung J, Kim HS, Moon WK, Hwang S, Moon A.
    Oncogene; 2018 Jan 04; 37(1):28-38. PubMed ID: 28846105
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation.
    Borensztajn K, Bijlsma MF, Reitsma PH, Peppelenbosch MP, Spek CA.
    Thromb Res; 2009 Jun 04; 124(2):219-25. PubMed ID: 19250659
    [Abstract] [Full Text] [Related]

  • 46. Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells.
    Mytilinaiou M, Bano A, Nikitovic D, Berdiaki A, Voudouri K, Kalogeraki A, Karamanos NK, Tzanakakis GN.
    IUBMB Life; 2013 Feb 04; 65(2):134-43. PubMed ID: 23297089
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The impact of conventional and heavy ion irradiation on tumor cell migration in vitro.
    Goetze K, Scholz M, Taucher-Scholz G, Mueller-Klieser W.
    Int J Radiat Biol; 2007 Feb 04; 83(11-12):889-96. PubMed ID: 18058372
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
    Ruseva Z, Geiger PX, Hutzler P, Kotzsch M, Luber B, Schmitt M, Gross E, Reuning U.
    Exp Cell Res; 2009 Jun 10; 315(10):1759-71. PubMed ID: 19371633
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Lumican inhibits cell migration through α2β1 integrin.
    Zeltz C, Brézillon S, Käpylä J, Eble JA, Bobichon H, Terryn C, Perreau C, Franz CM, Heino J, Maquart FX, Wegrowski Y.
    Exp Cell Res; 2010 Oct 15; 316(17):2922-31. PubMed ID: 20705068
    [Abstract] [Full Text] [Related]

  • 59. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
    Huang CY, Lee CY, Chen MY, Yang WH, Chen YH, Chang CH, Hsu HC, Fong YC, Tang CH.
    J Cell Physiol; 2009 Oct 15; 221(1):204-12. PubMed ID: 19496172
    [Abstract] [Full Text] [Related]

  • 60. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells.
    Park H, Kim Y, Lim Y, Han I, Oh ES.
    J Biol Chem; 2002 Aug 16; 277(33):29730-6. PubMed ID: 12055189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.